Multidisciplinary Evaluation of Patients With Hemophilia
NCT ID: NCT02198430
Last Updated: 2016-10-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104 participants
OBSERVATIONAL
2014-05-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Descriptive study of joint involvement in hemophilia patients with and without a history of hemarthrosis.
* Descriptive study of the alterations of periarticular muscle strength as a result of acute processes or the development of chronic articular sequelae.
* Descriptive study of biomechanical changes in lower limb joints and their impact on gait in patients with hemophilia.
* Descriptive study of the joint space, regarding hemarthrosis and synovitis, intraarticular by ultrasonography.
* Descriptive study of the relationship between skeletal muscle pathology in patients with hemophilia and their perceptions of it and their quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain and Joint Status With Psychosocial Factors in Patients With Hemophilia
NCT04715100
Transcultural Multidisciplinary Evaluation of Patients With Hemophili
NCT02199639
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
NCT02197611
COVID-19 Quarantine on Musculoskeletal Status in Hemophilia
NCT04491318
Multidimensional Assessment of Chronic Pain in Severe Haemophilia A
NCT07096349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Analyze and evaluate the skeletal muscle of patients with hemophilia involvement.
Describe the periarticular muscular deficit, depending on the degree of injury, age, presence of inhibitors and the development of physical activity.
Identify the relationship between the functional deficit by clinical assessment performed with the use of validated scales measure force production with patients.
Observe the presence of joint bleeds in children with hemophilia and synovial hypertrophy developing therein.
Detect biomechanical abnormalities of the lower limbs and their impact on gait in patients with hemophilia.
Assess the factors that influence the perception of illness and quality of life of patients with hemophilia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients with haemophilia recruited for multidisciplinary assessment of the main physical, functional and psychosocial variables.
No interventions assigned to this group
Control group
Children without hemophilia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of all ages (pediatric, adolescents, youth and adults).
* With or without joint involvement clinically diagnosed, and with or without a previous history of hemarthrosis joint loading.
* Patients with or without inhibitors.
Exclusion Criteria
* Patients diagnosed with other congenital coagulopathy (von Willebrand disease, etc..).
* Patients with neurological or cognitive impairments that prevent understanding the questionnaires and physical tests.
8 Years
60 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ANA TORRES-ORTUÑO
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rubén Cuesta-Barriuso, PhD
Role: PRINCIPAL_INVESTIGATOR
Catholic University San Antonio of Murcia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Murcia
Murcia, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOLISTIC
Identifier Type: -
Identifier Source: secondary_id
Hemo-HOLISTIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.